TuHURA Biosciences
HURA
9 hedge funds and large institutions have $40.4K invested in TuHURA Biosciences in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0.09% more ownership
Funds ownership: 0.12% → 0.2% (+0.09%)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
86% less capital invested
Capital invested by funds: $291K → $40.4K (-$251K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$179K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$43.2K |
| 3 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
+$29.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$13.5K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$879 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$808 |
HURA Hedge Fund Activity: Q4 2023 in Review
9 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q4 2023, worth a combined $40.4K — down 86% from $291K a quarter earlier.
Fund positioning in HURA was balanced in Q4 2023: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $179K. The largest seller was Morgan Stanley, exiting entirely with an estimated $13.5K sold.
- 9 institutional investors held TuHURA Biosciences (HURA) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $40.4K of TuHURA Biosciences stock for Q4 2023, down 86% quarter-over-quarter.
- 2 funds opened new TuHURA Biosciences positions in Q4 2023 and 2 closed out, a net change of 0 holders.
- The largest TuHURA Biosciences buyer in Q4 2023 was Acadian Asset Management, an estimated $179K added.
- The largest TuHURA Biosciences seller in Q4 2023 was Morgan Stanley, an estimated $13.5K sold.
Based on aggregated 13F filings for Q4 2023.